BERNARD LORD - I DON'T CARE WHAT THE REST OF THE WORLD SAY-

Sounds like Bernard Lord don't care what the rest of the world are saying - His stand of drugging and killing of our young children in New Brunswick will continue till October 15th, 2007!!!!!



FDA links fatal risk, children's drug


THE ASSOCIATED PRESS

September 30, 2005

WASHINGTON - The Food and Drug Administration warned doctors yesterday about reports of suicidal thinking in some children and adolescents taking Strattera, a drug used to treat attention deficit hyperactivity disorder.


Manufacturer Eli Lilly & Co. announced that a black-box warning will be added to the drug's label. Such a warning is the most serious that can be added. The company said

In a statement, the FDA said it "is advising health care providers and caregivers that children and adolescents being treated with Strattera should be closely monitored for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few months of therapy or when the dose is changed."

Eli Lilly said it provided the FDA results from Strattera clinical trials of 1,357 patients that found five youths taking the medication reported having suicidal thoughts, while none of 851 patients taking a placebo reported having any. One young person taking Strattera attempted suicide, but survived, company and FDA officials said.

There was no evidence of increased suicidal thoughts in adults taking Strattera, which also goes by the generic name atomoxetine, the Indianapolis-based company said.

"The actual risk is very low," said Dr. Thomas Laughren, head of the FDA's psychiatric drug unit. Despite the warning, he said, "FDA still views Strattera as an effective drug." At the FDA's request, Eli Lilly will publish a guide for doctors and pharmacists to give to people who are prescribed Strattera.

The warning is the result of a larger FDA review of psychiatric drugs and their possible association with suicide.

Old drug studies are being reviewed for occurrences of suicides and suicidal thoughts. Last year, the FDA ordered warnings on all antidepressants that they "increase the risk of suicidal thinking and behavior" in children.

Strattera won praise from some doctors and parents when it became available because, unlike Ritalin, it is not a stimulant that can be addictive. But its chemical makeup is similar to certain antidepressants.

A review of other ADHD drugs continues, Laughren said.